{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:48:36Z","timestamp":1755218916757,"version":"3.43.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/ http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Neurofibromatosis type I (NF1) is a genetic disorder characterized by the development of multiple benign tumors along nerves in the skin, brain, and other parts of the body. It is associated with a range of clinical manifestations, including skin lesions, neurofibromas, and ocular abnormalities, which can significantly impact a patient\u2019s quality of life. Management of NF1 is particularly challenging in resource-limited settings due to limited access to diagnostic and therapeutic resources.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical presentation:<\/jats:title>\n            <jats:p>A 62-year-old woman with a known history of NF1 presented with progressive visual impairment. Her condition began in childhood with multiple hyperpigmented skin macules, which developed into numerous cutaneous tumors over time. Examination revealed numerous neurofibromas, caf\u00e9-au-lait spots, and axillary freckling. Significant visual impairment was caused by large fibromas on her eyelids. Histological analysis confirmed benign nerve tissue tumors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical discussion:<\/jats:title>\n            <jats:p>The management strategy in this resource-limited setting focused on regular monitoring, patient education, symptomatic treatment, and multidisciplinary care. Despite the limitations, the patient\u2019s condition was managed effectively through these adapted strategies. The importance of genetic testing for confirmation and further management was noted but not performed due to resource constraints.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This case highlights the complexities of managing NF1 in resource-limited settings, emphasizing the need for adaptable management approaches. Multidisciplinary care and patient education were crucial in improving the patient\u2019s quality of life. This case underscores the importance of early diagnosis and intervention to prevent complications like visual impairment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ms9.0000000000002482","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T20:06:21Z","timestamp":1724443581000},"page":"6203-6207","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Managing neurofibromatosis type I and vision impairment in a resource-limited setting: a case study and multidisciplinary approach"],"prefix":"10.1097","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5051-2684","authenticated-orcid":false,"given":"Pratik","family":"Adhikari","sequence":"first","affiliation":[{"name":"Koirala Institute of Health Sciences, Dharan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabin","family":"Bhujel","sequence":"additional","affiliation":[{"name":"College of Medical Sciences, Bharatpur, Chitwan, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,10]]},"reference":[{"key":"R1-20250806","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/B978-0-444-52902-2.00053-9","article-title":"Neurofibromatosis type 1 (NF1): diagnosis and management","volume":"115","author":"Ferner","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"R2-20250806","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1474-4422(14)70063-8","article-title":"Neurofibromatosis type 1: a multidisciplinary approach to care","volume":"13","author":"Hirbe","year":"2014","journal-title":"Lancet Neurol"},{"key":"R3-20250806","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1542\/peds.2007-3204","article-title":"Neurofibromatosis type 1 revisited","volume":"123","author":"Williams","year":"2009","journal-title":"Pediatrics"},{"key":"R4-20250806","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.ajpath.2010.12.056","article-title":"The pathoetiology of neurofibromatosis 1","volume":"178","author":"Jouhilahti","year":"2011","journal-title":"Am J Pathol"},{"key":"R5-20250806","doi-asserted-by":"crossref","first-page":"17004","DOI":"10.1038\/nrdp.2017.4","article-title":"Neurofibromatosis type 1","volume":"3","author":"Gutmann","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"R6-20250806","first-page":"704","article-title":"The neurofibromatoses: a genomics and systems biology perspective","volume":"7","author":"Hirbe","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"R7-20250806","first-page":"16","article-title":"Neurofibromatosis type 1: optimizing management in the era of precision medicine","volume":"30","author":"Widemann","year":"2019","journal-title":"Ann Oncol"},{"key":"R8-20250806","first-page":"531","article-title":"Use of the 6-criteria diagnostic checklist in the diagnosis of neurofibromatosis type 1 in the pediatric setting: a population-based study","volume":"70","author":"Wolkenstein","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"R9-20250806","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2008.12.051","article-title":"Neurofibromatosis type 1","volume":"61","author":"Boyd","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"R10-20250806","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/JS9.0000000000000373","article-title":"The SCARE 2023 guideline: updating consensus Surgical CAse REport (SCARE) guidelines","volume":"109","author":"Sohrabi","year":"2023","journal-title":"Int J Surg (London, England)"},{"key":"R11-20250806","first-page":"733","article-title":"Pediatric plexiform neurofibromas: impact on morbidity and mortality in neurofibromatosis type 1","volume":"161","author":"Prada","year":"2012","journal-title":"J Pediatr"},{"key":"R12-20250806","first-page":"3840","article-title":"Neurofibromatosis type 1 (NF1) gene mutation analysis: from DNA extraction to sequencing","volume":"59","author":"Blanchard","year":"2012","journal-title":"J Vis Exp"},{"key":"R13-20250806","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.mcna.2019.07.004","article-title":"The diagnosis and management of neurofibromatosis type 1","volume":"103","author":"Ly","year":"2019","journal-title":"Med Clin North Am"},{"key":"R14-20250806","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1101\/gr.142604.112","article-title":"Somatic neurofibromatosis type 1 (NF1) inactivation characterizes NF1-associated pilocytic astrocytoma","volume":"23","author":"Gutmann","year":"2013","journal-title":"Genome Res"},{"key":"R15-20250806","first-page":"971","article-title":"KIAA1549-BRAF and FGFR1-TACC1 are the most prevalent gene fusions in sporadic and NF1-related pilocytic astrocytomas","volume":"44","author":"Khuong-Quang","year":"2012","journal-title":"Nat Genet"},{"key":"R16-20250806","first-page":"520","article-title":"Emerging molecular insights into the pathogenesis and treatment of NF1-associated tumors","volume":"11","author":"Hirbe","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"R17-20250806","first-page":"2378","article-title":"Methylation profiling differentiates between germline and somatic NF1 mutations in gliomas","volume":"131","author":"Harder","year":"2012","journal-title":"Int J Cancer"},{"key":"R18-20250806","first-page":"247","article-title":"Early diagnosis and follow-up of neurofibromatosis type 1: a complex challenge","volume":"168","author":"North","year":"2016","journal-title":"J Pediatr"},{"key":"R19-20250806","first-page":"43","article-title":"Evaluation of the clinical application of NF1 diagnostic criteria","volume":"84","author":"Guillot","year":"2013","journal-title":"Clin Genet"},{"key":"R20-20250806","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/GIM.0b013e3181bf15e3","article-title":"Clinical and genetic aspects of neurofibromatosis 1","volume":"12","author":"Jett","year":"2010","journal-title":"Genet Med"},{"key":"R21-20250806","first-page":"9","article-title":"Pediatric neurofibromatosis type 1 and its management","volume":"19","author":"Nilsson","year":"2017","journal-title":"Curr Treat Options Neurol"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000002482","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:22:25Z","timestamp":1754486545000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000002482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,26]]},"references-count":21,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000002482","relation":{},"ISSN":["2049-0801"],"issn-type":[{"type":"electronic","value":"2049-0801"}],"subject":[],"published":{"date-parts":[[2024,8,26]]},"assertion":[{"value":"2024-07-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}